Human(ized) monoclonal antibodies in atopic patients: state of the art
Asthma is an important chronic disease affecting a lot of people worldwide. Treatment options for asthma like biological agents are being developed more frequently nowadays. Despite a lot of treatment options, some patients still remain symptomatic. As more and more practitioners choose treatment...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2020/07/27
|
| In: |
Central European journal of immunology
Year: 2020, Volume: 45, Issue: 2, Pages: 195-201 |
| ISSN: | 1644-4124 |
| DOI: | 10.5114/ceji.2020.97909 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.5114/ceji.2020.97909 Verlag, lizenzpflichtig, Volltext: https://www.termedia.pl/Human-ized-monoclonal-antibodies-in-atopic-patients-state-of-the-art,10,41515,0,1.html 
|
| Author Notes: | Arzu Didem Yalcin, Kevser Onbasi, Rusen Uzun, Felix Herth, Philipp Albert Schnabel |
| Summary: | Asthma is an important chronic disease affecting a lot of people worldwide. Treatment options for asthma like biological agents are being developed more frequently nowadays. Despite a lot of treatment options, some patients still remain symptomatic. As more and more practitioners choose treatment... |
|---|---|
| Item Description: | Gesehen am 17.09.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1644-4124 |
| DOI: | 10.5114/ceji.2020.97909 |